Michéle Dargis

Title: Michéle Dargis: Innovator in Influenza Vaccine Development

Introduction

Michéle Dargis is a prominent inventor based in Québec, Canada. She has made significant contributions to the field of vaccine development, particularly in the area of influenza. Her innovative work has the potential to enhance the effectiveness of existing vaccines and improve public health outcomes.

Latest Patents

Dargis holds a patent for "Soluble recombinant influenza antigens." This invention provides a recombinant soluble trimeric hemagglutinin (rHA) protein that comprises a hemagglutinin ectodomain and an oligomerization domain. The rHA is produced as a soluble homotrimer and may further include a signal peptide and/or an endoplasmic reticulum (ER) retention signal. The invention also encompasses nucleic acids encoding the rHA, as well as vectors and chimeric constructs that include the nucleic acid. Methods for producing the rHA are also detailed in the patent. The rHA described may be utilized to formulate influenza vaccines or to enrich existing vaccines. Dargis has 1 patent to her name.

Career Highlights

Michéle Dargis has established herself as a key figure in the biotechnology sector. She is currently associated with Medicago Inc., a company known for its innovative approaches to vaccine development. Her work at Medicago has been instrumental in advancing research and development in the field of influenza vaccines.

Collaborations

Dargis collaborates with talented professionals in her field, including Manon Couture and Nathalie Landry. These collaborations enhance the research efforts and contribute to the success of their projects.

Conclusion

Michéle Dargis is a notable inventor whose work in influenza vaccine development is paving the way for more effective immunization strategies. Her contributions are vital to the ongoing efforts to combat influenza and improve public health.